Berlex/Schering AG discover highly potent nonamidine factor Xa inhibitor with oral bioavailability April 17, 2001
Nonbenzamidine factor Xa inhibitors from DuPont with excellent in vitro profile and improved PK April 12, 2001
Replacement of benzamidine with azaindole in Aventis series provides oral factor Xa inhibitors April 3, 2001